Miralax and Strabismus - a phase IV clinical study of FDA data

Summary:

Strabismus is reported as a side effect among people who take Miralax (polyethylene glycol 3350), especially for people who are female, 50-59 old, also take Famotidine, and have Body height below normal.

The phase IV clinical study analyzes which people have Strabismus when taking Miralax. It is created by eHealthMe based on reports of 80,819 people who have side effects when taking Miralax from the FDA, and is updated regularly.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

What is Strabismus?

Strabismus (a disorder in which the two eyes do not line up in the same direction) is found to be associated with 344 drugs and 774 conditions by eHealthMe. Check the latest studies of Strabismus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

80,819 people reported to have side effects when taking Miralax.
Among them, 16 people (0.02%) have Strabismus.

Among these 16 people:

What is the gender of people who have Strabismus when taking Miralax? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Strabismus when taking Miralax? *

What are other drugs people take besides Miralax? *

What are other side effects people have besides Strabismus? *

Nausea (feeling of having an urge to vomit): 6 people, 37.50%
Oropharyngeal Pain: 5 people, 31.25%
Headache (pain in head): 5 people, 31.25%
Skin Blushing/flushing (a sudden reddening of the face, neck): 4 people, 25.00%
Abdominal Pain: 4 people, 25.00%
Memory Loss: 4 people, 25.00%
Cough: 4 people, 25.00%
Hoarseness Or Changing Voice: 4 people, 25.00%
Dyspnea (difficult or laboured breathing): 4 people, 25.00%
Fatigue (feeling of tiredness): 4 people, 25.00%

What are the existing conditions these people have? *

Body Height Below Normal: 4 people, 25.00%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 18.75%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 18.75%
Cerebral Palsy: 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Type 2 Diabetes: 1 person, 6.25%
Hypersensitivity: 1 person, 6.25%
Depression: 1 person, 6.25%
Diabetes: 1 person, 6.25%
Dyspnea (difficult or laboured breathing): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Miralax and have Strabismus?

- Check whether Strabismus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miralax:

Miralax (81,754 reports)

Strabismus treatments and more:

Strabismus (3,725 reports)

Browse all side effects of Miralax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Strabismus:

Strabismus (344 drugs)

Browse all the conditions that are associated with Strabismus:

Strabismus (774 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Miralax) and Miralax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.